The Department of Health and Human Services is reevaluating a $590 million contract for avian influenza mRNA vaccines that the prior administration struck with Moderna, Bloomberg first reported on ...

An avian flu vaccine contract with Moderna may be suspended, pending review of the contract by the current administration, according to a recent Reuters news story. The vaccine contract was ...

The 1918 flu pandemic, also known as the Spanish flu, caught the world by surprise just as the First World War was coming to ...

Moderna’s mRNA-based bird flu vaccine mRNA-1018 is undergoing a Phase 1/2 study targeting H5 and H7 avian influenza viruses. In January 2025, the US Department of Health and Human Services (HHS ...

Notably, Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses, or bird flu. It primarily affects birds, but it is closely monitored due to the risk of mutating and spreading ...

With support from BARDA, Moderna has been developing an mRNA-based vaccine for avian flu for the past several years. That vaccine candidate is on the verge of entering pivotal Phase 3 trials.

Highly pathogenic avian influenza A (H5) viruses were detected ... has died. For more, read: Moderna's stock stumbles on report HHS is reviewing $590 million award for bird-flu vaccine The CDC ...

The deadly H7N9 strain was detected on a poultry farm in Noxubee, Mississippi, last week, for the first time since 2017.

The U.S. government awarded Moderna $590 million in January to ... of a pre-pandemic mRNA-based vaccine against the H5N1 avian influenza. "While it is crucial that the U.S. Department of Health ...

Avian flu has wreaked havoc in other parts of the world. According to the World Organization for Animal Health, the United ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.